Kimialys
Biosensing surface chemistry and lateral flow assay development for diagnostics and drug discovery labs
Highlights
- Hiring1 open role
- New on EvolcAdded 2026-11-02
About Kimialys
Kimialys is a biosensing company that develops and manufactures products and services built on its proprietary K-One surface chemistry, a self-assembled monolayer for gold nanoparticles, chips and electrodes. Its offerings include SPR services, custom K-One sensor chips, an antibody selection platform, lateral flow assay (LFA) services and K-One gold bioconjugates.
Its customers are R&D teams, diagnostic developers and pharmaceutical companies working on diagnostics, drug discovery and bioanalysis. The company has delivered over 100 projects and supplies ready-to-use gold bioconjugates in small to large volumes.
Kimialys was founded in 2020 and is headquartered in Paris, France, with a laboratory at the Paris Biotech Santé incubator in Cochin. It has announced a €3.6 million Series A round and lists an open Quality Control Scientist role in Paris.
Product: K-One surface chemistry-based SPR services, custom sensor chips, antibody selection platform, LFA development and gold bioconjugates.
Jobs at Kimialys (1)
Kimialys is hiring for one role in manufacturing, based in Paris.
Quality Control Scientist
New on Evolc
Leadership
- Claude NOGUES · Co-founder & Chief Scientific OfficerSource: company website
- Cyril GILBERT · Co-founder & Chief Executive OfficerSource: company website
More biotech & pharma companies
LFB Biomanufacturing
Contract development and GMP manufacturing of biologic drugs for biotech and pharma developers, from cell lines to clinicalNew on EvolcLys Therapeutics
Biotech developing an antibody to treat blood-brain barrier dysfunction and neuroinflammation in neurological diseasesNew on EvolcMaat Pharma
Develops microbiome-based cancer therapeutics for patients with severe oncology diseasesNew on EvolcMabqi
Discovers and develops therapeutic antibodies for biopharmaceutical partners and oncology treatment programsNew on EvolcMabsilico
AI-based antibody candidate design for biotech and pharma companies, with candidates delivered in 21 daysNew on EvolcMetafora Biosystems
Develops single-cell metabolic testing and analysis for diagnostic and cell therapy applicationsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4Medium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
- Integration code on pageinitialization/configuration expression
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
Content management
- WebflowHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.